Evidence map›Paper›PMID 26226135›Full record

ArticlePloS one2015

GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway.

Barun Mahata, Soumika Biswas, Patricia Rayman, Ali Chahlavi, Jennifer Ko, Ashish Bhattacharjee, Yu-Teh Li, Yuntao Li, Tanya Das, Gaurisankar Sa and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Effect of differential hypoxia-related gene expression on glioblastoma.The Journal of international medical research · 2021
    Article
  7. Review
  8. Soluble epoxide hydrolase (Archives of medical science : AMS · 2021
    Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Barun MahataDivision of Molecular Medicine, Bose Institute, Kolkata, India.
Soumika BiswasDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States of America.
Patricia RaymanDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States of America.
Ali ChahlaviSpine and Brain Institute, St. Vincent Medical Center, Jacksonville, Florida, United States of America.
Jennifer KoPathology Institute, Cleveland Clinic, Cleveland, United States of America.
Ashish BhattacharjeeDepartment of Biotechnology, National Institute of Technology, Durgapur, India.
Yu-Teh LiDepartment of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, United States of America.
Yuntao LiDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States of America.
Tanya DasDivision of Molecular Medicine, Bose Institute, Kolkata, India; Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States of America.
Gaurisankar SaDivision of Molecular Medicine, Bose Institute, Kolkata, India; Department of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States of America.
Baisakhi RaychaudhuriBrain Tumor and Neuro-oncology Center in the Neurological Institute, Cleveland Clinic, Cleveland, United States of America.
Michael A VogelbaumBrain Tumor and Neuro-oncology Center in the Neurological Institute, Cleveland Clinic, Cleveland, United States of America.
Charles TannenbaumDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States of America.
James H FinkeDepartment of Immunology, Lerner Research Institute, Cleveland Clinic, Cleveland, United States of America.
Kaushik BiswasDivision of Molecular Medicine, Bose Institute, Kolkata, India.
Cleveland Clinic Lerner College of Medicine · USBose Institute · INCleveland Clinic · USNational Institute of Technology Durgapur · INSt Vincent Medical Center · USThe Neurological Institute · US

Funding

Tumor Induced Dysregulation of T Cell ImmunityR01CA116255 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI FINKE, JAMES H · 2006 to 2010
$1.3M
NCI NIH HHS R01 CA116255NCI NIH HHS R01-CA116255
6 · The paper itself

Abstract

Previously we demonstrated that human glioblastoma cell lines induce apoptosis in peripheral blood T cells through partial involvement of secreted gangliosides. Here we show that GBM-derived gangliosides induce apoptosis through involvement of the TNF receptor and activation of the caspase cascade. Culturing T lymphocytes with GBM cell line derived gangliosides (10-20 μg/ml) demonstrated increased ROS production as early as 18 hrs as indicated by increased uptake of the dye H2DCFDA while western blotting demonstrated mitochondrial damage as evident by cleavage of Bid to t-Bid and by the release of cytochrome-c into the cytosol. Within 48-72 hrs apoptosis was evident by nuclear blebbing, trypan blue positivity and annexinV/7AAD staining. GBM-ganglioside induced activation of the effector caspase-3 along with both initiator caspases (-9 and -8) in T cells while both the caspase-8 and -9 inhibitors were equally effective in blocking apoptosis (60% protection) confirming the role of caspases in the apoptotic process. Ganglioside-induced T cell apoptosis did not involve production of TNF-α since anti-human TNFα antibody was unable to protect T cells from nuclear blebbing and subsequent cell death. However, confocal microscopy demonstrated co-localization of GM2 ganglioside with the TNF receptor and co-immunoprecipitation experiments showed recruitment of death domains FADD and TRADD with the TNF receptor post ganglioside treatment, suggesting direct interaction of gangliosides with the TNF receptor. Further confirmation of the interaction between GM2 and TNFR1 was obtained from confocal microscopy data with wild type and TNFR1 KO (TALEN mediated) Jurkat cells, which clearly demonstrated co-localization of GM2 and TNFR1 in the wild type cells but not in the TNFR1 KO clones. Thus, GBM-ganglioside can mediate T cell apoptosis by interacting with the TNF receptor followed by activation of both the extrinsic and the intrinsic pathway of caspases.

Indexed as

ApoptosisCaspasesCell Line, TumorGene Knockout TechniquesGlioblastomaG(M2) GangliosideHumansImmunoprecipitationJurkat CellsMicroscopy, ConfocalReactive Oxygen SpeciesReceptors, Tumor Necrosis FactorSignal TransductionT-LymphocytesCaspasesG(M2) GangliosideReactive Oxygen SpeciesReceptors, Tumor Necrosis Factor

Identifiers

PMID26226135
PMCPMC4520498
OpenAlexW980945599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.